Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough A, Grabensee B, Röher H-D
Department of Surgery, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Langenbecks Arch Surg. 2003 Jan;387(9-10):348-54. doi: 10.1007/s00423-002-0322-x. Epub 2002 Dec 14.
Subtotal parathyroidectomy (SPTX) and total parathyroidectomy with autotransplantation (TPTX and AT) are standard procedures in the treatment of renal autonomous hyperparathyroidism. In contrast to primary hyperparathyroidism, the persistence/recurrence rate is reported of up to 12.0%.
Between 1986 and 2000 we operated on 304 patients with renal autonomous hyperparathyroidism including 14 patients who were admitted after a primary operation in an outside hospital. Mean observation period was 51.4+/-38.9 months.
The overall persistence/recurrence rate in our patients was 9.0% (26/290). After SPTX, excluding patients with an incomplete operation, it was 3.7%, and after TPTX and AT it was 6.0%. Reasons for developing recurrent or persistent disease in these patients were removal of less than 3.5 glands ( n=12), hyperplastic autograft ( n=5), and supernumerary gland ( n=4). After the first reoperation 7 patients (26.9%) had persistent or recurrent disease.
An incomplete primary operation caused by missed cervical glands was the major reason for persistent ( n=8) or recurrent ( n=4) disease after different operative strategies in renal autonomous hyperparathyroidism.
甲状旁腺次全切除术(SPTX)和甲状旁腺全切除术加自体移植术(TPTX和AT)是治疗肾性自主性甲状旁腺功能亢进的标准术式。与原发性甲状旁腺功能亢进不同,据报道其持续/复发率高达12.0%。
1986年至2000年间,我们对304例肾性自主性甲状旁腺功能亢进患者进行了手术,其中14例是在外院初次手术后入院的。平均观察期为51.4±38.9个月。
我们患者的总体持续/复发率为9.0%(26/290)。在SPTX后,排除手术不完整的患者,该率为3.7%,在TPTX和AT后为6.0%。这些患者出现复发或持续性疾病的原因是切除的腺体少于3.5个(n = 12)、自体移植增生(n = 5)和额外腺体(n = 4)。首次再次手术后,7例患者(26.9%)有持续性或复发性疾病。
在肾性自主性甲状旁腺功能亢进的不同手术策略后,因遗漏颈部腺体导致的初次手术不完整是持续性(n = 8)或复发性(n = 4)疾病的主要原因。